You are here

SPN-830

Potential FDA approval for Supernus’s SPN-830 in Parkinson’s but challenges remain

Clinical Trials Arena

Mon, 10/16/23 - 10:18 am

Parkinson's Disease

Working its way through a CRL on lead drug, Supernus taps $150M loan

Endpoints

Wed, 02/15/23 - 06:17 pm

Supernus Pharmaceuticals

Parkinson's Disease

FDA spurns Supernus for Parkinson's drug, noting application issues 'across several areas'

Endpoints

Mon, 10/10/22 - 06:47 pm

Supernus Pharmaceuticals

Parkinson's Disease

FDA hits Supernus with double whammy, handing biotech a CRL and RTF on same day

Endpoints

Tue, 11/10/20 - 10:40 am

Parkinson's Disease